Back to DE D. E. Shaw & Co., Inc.

NVAXNVAX

Showing 8 of 27 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in Novavax, Inc.

Yes. D. E. Shaw holds 5,650,905 shares of NVAX (Novavax), worth $53.2M, as of its Q2 2026 13F filing. It reduced the position by 2,058,953 shares (-26.7%) from Q1 2026. D. E. Shaw has held NVAX since Q3 2023, across 12 quarterly 13F filings.

Current Value

$53.2M

Current Shares

5.7M

Total Value Change

-$21.8M

Total Shares Change

-286,260

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
5.7M
-26.7%
$53.2M0.0%$9.42
0
2026-Q1
Increased
7.7M
+28.6%
$62.8M0.0%$8.14
37
2025-Q4
Increased
6M
+40.2%
$40.3M0.0%$6.72
39
2025-Q3
Increased
4.3M
+8.4%
$37.1M0.0%$8.67
32
2025-Q2
Increased
3.9M
+20.9%
$24.8M0.0%$6.30
34
2025-Q1
Decreased
3.3M
-43.7%
$20.9M0.0%$6.41
0
2024-Q4
Decreased
5.8M
-2.5%
$46.6M0.0%$8.04
0
2024-Q3
Decreased
5.9M
-6.1%
$75M0.1%$12.63
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used